Patrick Skacel is a Senior Counsel in the Life Sciences Group at Pearl Cohen’s New York office. His practice focuses on a broad range of patent matters, primarily in the fields of biotechnology, pharmaceuticals, and chemistry. Patrick has extensive experience preparing and prosecuting patent applications, rendering invalidity, freedom to operate, non-infringement, and patentability opinions, and providing strategic advice and counselling to clients on their patent portfolios. His work also has included performing comprehensive IP due diligence in connection with mergers, acquisitions, and capital investments, and he has been involved in various aspects of adversarial patent proceedings.
While a student at Fordham Law School, Patrick served as a Notes and Articles Editor of the Fordham International Law Journal. Before earning his law degree, he gained biotechnology research experience in both academic and industry settings, where he researched mammalian receptor systems and their functions and evaluated the pharmacokinetics and metabolism of investigational new drugs and drug candidates.
Prior to joining Pearl Cohen, Patrick was an associate with an IP boutique in New York and a partner with Rothwell, Figg, Ernst & Manbeck, P.C. in Washington, D.C.